REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pt Indofarma Tbk (Indonesia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pt Indofarma Tbk Profile Updated: August 29, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Indofarma Tbk is a company in Indonesia, with a head office in Jakarta. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on April 19, 1996. 788 (2024) employees currently work for Pt Indofarma Tbk. The company’s latest financial report indicates a net sales revenue drop of 3% in Q3C2025. Over the same period, its total assets decreased by 23.32%. In 2025, Pt Indofarma Tbk’s net profit margin increased by 25.72%.

Headquarters
Jl. Tambak No.2, Manggarai
Jakarta; Jakarta; Postal Code: 13150

Contact Details: Purchase the Pt Indofarma Tbk report to view the information.

Website: http://www.indofarma.co.id

Basic Information
Total Employees:
Purchase the Pt Indofarma Tbk report to view the information.
Outstanding Shares:
Purchase the Pt Indofarma Tbk report to view the information.
Financial Auditors:
Purchase the Pt Indofarma Tbk report to view the information.
Incorporation Date:
April 19, 1996
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
80.664%
Purchase this report to view the information.
11.994%
Purchase this report to view the information.
7.34%
Subsidiaries
Pt Indofarma Global Medika
99.99%
Company Performance
Financial values in the chart are available after Pt Indofarma Tbk report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
-3%▼
Total Operating Revenue
-3.37%▼
Operating Profit
15.56%▲
EBITDA
19.95%▲
Net Profit/Loss for the Period
23.66%▲
Total Assets
-23.32%▼
Total Equity
8.21%▲
Operating Profit Margin
12.35%▲
Net Profit Margin
25.72%▲
Return on Equity (ROE)
-2.89%▼
Debt / Equity
-14.35%▼
Quick Ratio
0%
Cash Ratio
0.02%▲

Similar companies

PT Emjebe Pharma
 
Pt Kalbe Farma Tbk
PT Otasindo Prima Satwa
 
PT Eagle Indo Pharma
Pt Tempo Scan Pacific Tbk
 
Pt Soho Global Health Tbk
Pt Phyto Kemo Agung Farma
 
Pt Aksamala Adi Andana
Pt Daun Teratai Pharmaceutical
 
Pt Daewoong Infion
Pt Brigit Biofarmaka Teknologi Tbk
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo